More extensive CLL studies have already shown that approximately 5% of CLL patients are ROR1 negative [16], and due to its high prevalence in CLL, ROR1 is currently used via FC to refine the diagnosis of this disease [10, 17]. Here, ROR1 is linked to B-cell chronic lymphocytic leukemia.